Chemomab Therapeutics Total Assets

Chemomab Therapeutics (CMMB) currently reports a total assets of $12M as of March 2026. That compares with $13M in the prior-year period — down 7.9% year over year. Use the charts on this page to explore Chemomab Therapeutics's total assets history and peer comparisons.

Chemomab Therapeutics's total assets decreased from $13M to $12M — a 7.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chemomab Therapeutics reported $12M in total assets as of March 2026. That compares with $13M in the prior-year period — down 7.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Chemomab Therapeutics, and consider following CMMB for alerts when major investors trade the stock.

Chemomab Therapeutics is classified in the Healthcare sector. On total assets, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CMMB with unrelated industries.